EG245190 Inhibitors
EG245190 inhibitors are a class of chemical compounds specifically designed to block the function of the **EG245190** protein, which is believed to play a significant role in key cellular processes such as signal transduction, molecular transport, or enzymatic activity. These inhibitors act by binding to critical active sites or regions of the EG245190 protein, effectively preventing it from carrying out its usual biological functions. This disruption enables researchers to study the downstream effects of EG245190 inhibition on various cellular systems, such as the regulation of metabolic pathways, intracellular signaling, or protein synthesis. By targeting EG245190, scientists gain a clearer understanding of the protein's role in maintaining the integrity of cellular operations and how its activity influences other molecular interactions within the cell.
The use of EG245190 inhibitors is essential for examining how the inhibition of this protein impacts broader biochemical pathways and networks. Researchers can investigate how blocking EG245190 affects related cellular functions and how cells compensate for the loss of its activity. Additionally, these inhibitors allow scientists to map the molecular relationships between EG245190 and other cellular components, offering insights into how this protein contributes to maintaining cellular balance and stability. By studying the consequences of EG245190 inhibition, researchers can explore the feedback loops and regulatory mechanisms that are activated in response to its absence, providing a more comprehensive view of its role in complex biological systems. Ultimately, EG245190 inhibitors serve as powerful tools for uncovering the precise molecular dynamics that govern key cellular processes and for gaining a deeper understanding of the protein's function in various cellular contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV-939, a tankyrase inhibitor, indirectly inhibits Tpbgl by negatively regulating the canonical Wnt signaling pathway. This compound promotes β-catenin degradation, affecting the pathway at the molecular level and leading to the suppression of Tpbgl's negative regulatory role in Wnt signaling. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
IWP-2, a Wnt secretion inhibitor, indirectly influences Tpbgl by disrupting Wnt ligand secretion. By inhibiting Porcupine, a key enzyme in Wnt ligand acylation, IWP-2 attenuates canonical Wnt signaling, impacting Tpbgl's negative regulatory function in the pathway and modulating cellular responses. | ||||||
LGK 974 | 1243244-14-5 | sc-489380 sc-489380A | 5 mg 50 mg | $359.00 $1295.00 | 2 | |
LGK-974, a Porcupine inhibitor, indirectly affects Tpbgl by blocking Wnt ligand acylation. This inhibition disrupts the canonical Wnt signaling pathway, altering the cellular context in which Tpbgl operates as a negative regulator. | ||||||
PRI-724 | 1422253-38-0 | sc-507535 | 25 mg | $260.00 | ||
PRI-724, a CBP/β-catenin inhibitor, indirectly modulates Tpbgl by targeting the β-catenin/CBP interaction. This compound impedes the activation of Wnt target genes, affecting Tpbgl's regulatory role in the canonical Wnt signaling pathway and influencing cellular responses mediated by this pathway. | ||||||
β-Catenin/Tcf Inhibitor, FH535 | 108409-83-2 | sc-221398 sc-221398A | 10 mg 50 mg | $182.00 $374.00 | 7 | |
FH535, a dual Wnt/β-catenin and PPAR-γ inhibitor, indirectly influences Tpbgl by targeting multiple signaling pathways. By inhibiting Wnt/β-catenin and PPAR-γ, FH535 disrupts the cellular context in which Tpbgl operates as a negative regulator, leading to modulation of the canonical Wnt signaling pathway and altered cellular responses. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
Wnt-C59, a Porcupine inhibitor, indirectly inhibits Tpbgl by disrupting Wnt ligand acylation. This interference with Wnt signaling at its source impacts Tpbgl's negative regulatory function in the pathway, influencing cellular responses and altering the molecular context in which Tpbgl operates. | ||||||
KY02111 | 1118807-13-8 | sc-397043 sc-397043A | 5 mg 25 mg | $79.00 $336.00 | ||
KY02111, a Wnt production inhibitor, indirectly affects Tpbgl by targeting Wnt ligand production. By disrupting the formation of the Wnt ligand, KY02111 attenuates canonical Wnt signaling, impacting Tpbgl's negative regulatory function in the pathway and modulating cellular responses. | ||||||
Cercosporin | 35082-49-6 | sc-255013 | 5 mg | $459.00 | 1 | |
Cercosporin, a tankyrase inhibitor, indirectly inhibits Tpbgl by negatively regulating the canonical Wnt signaling pathway. This compound promotes β-catenin degradation, affecting the pathway at the molecular level and leading to the suppression of Tpbgl's negative regulatory role in Wnt signaling. | ||||||
PKF118-310 | 84-82-2 | sc-364590 sc-364590A | 5 mg 25 mg | $180.00 $651.00 | ||
PKF118-310, a Wnt/β-catenin signaling inhibitor, indirectly influences Tpbgl by targeting multiple components of the pathway. By disrupting Wnt/β-catenin signaling, PKF118-310 modulates the cellular context in which Tpbgl operates as a negative regulator, leading to altered canonical Wnt signaling and cellular responses. | ||||||
JW 55 | 664993-53-7 | sc-364517 sc-364517A | 10 mg 50 mg | $172.00 $726.00 | ||
JW55, a tankyrase inhibitor, indirectly inhibits Tpbgl by negatively regulating the canonical Wnt signaling pathway. This compound promotes β-catenin degradation, affecting the pathway at the molecular level and leading to the suppression of Tpbgl's negative regulatory role in Wnt signaling. | ||||||